{
  "template": "Forge Healthcare AI Risk Assessment",
  "version": "1.0",
  "aligned_with": ["NIST AI RMF 1.0 MEASURE Function", "FDA SaMD Framework", "HIPAA Security Rule"],
  "risk_dimensions": {
    "patient_safety": {
      "name": "Patient Safety",
      "weight": 0.25,
      "key_questions": [
        "Could this tool cause harm through incorrect outputs?",
        "What is the clinical severity of potential false positives/negatives?",
        "Does the tool have appropriate failsafe mechanisms?",
        "Is human oversight required for all clinical decisions?"
      ],
      "assessment_methods": ["Clinical validation studies", "Failure mode analysis", "Adverse event review"],
      "scoring_criteria": {
        "1": "Minimal patient interaction, no clinical decision impact",
        "2": "Indirect clinical influence, low severity potential",
        "3": "Moderate clinical influence, reversible harm potential",
        "4": "Direct clinical influence, significant harm potential",
        "5": "Life-critical decisions, irreversible harm potential"
      }
    },
    "bias_fairness": {
      "name": "Bias & Fairness",
      "weight": 0.20,
      "key_questions": [
        "Does this tool perform equitably across demographic groups?",
        "Was training data representative of our patient population?",
        "Have disparate impact ratios been calculated?",
        "Are there known demographic performance gaps?"
      ],
      "assessment_methods": ["Disaggregated performance metrics", "Disparate impact analysis", "Fairness testing"],
      "scoring_criteria": {
        "1": "No demographic performance variation, representative data",
        "2": "Minor variations, well-documented and monitored",
        "3": "Moderate disparities identified, remediation underway",
        "4": "Significant disparities across key demographic groups",
        "5": "Severe bias with potential for systematic discrimination"
      },
      "protected_categories": ["Race", "Ethnicity", "Gender", "Age", "Socioeconomic Status", "Insurance Type", "Language", "Disability Status"]
    },
    "data_privacy": {
      "name": "Data Privacy",
      "weight": 0.15,
      "key_questions": [
        "What PHI does this system access and how is it protected?",
        "Is there a Business Associate Agreement in place?",
        "Does data processing comply with minimum necessary standard?",
        "Are data retention policies appropriate?"
      ],
      "assessment_methods": ["Privacy impact assessment", "Data flow mapping", "HIPAA compliance review"],
      "scoring_criteria": {
        "1": "No PHI access, anonymized data only",
        "2": "Limited PHI access, strong controls, BAA in place",
        "3": "Moderate PHI access, standard HIPAA controls",
        "4": "Broad PHI access, complex data flows, third-party processing",
        "5": "Extensive PHI access including sensitive categories, cross-border data flows"
      }
    },
    "clinical_validity": {
      "name": "Clinical Validity",
      "weight": 0.15,
      "key_questions": [
        "Is this tool's accuracy validated for our patient population?",
        "Are published performance metrics applicable to our context?",
        "Has local validation been performed?",
        "Are there peer-reviewed studies supporting this tool?"
      ],
      "assessment_methods": ["Local validation studies", "Literature review", "Clinical outcome correlation"],
      "scoring_criteria": {
        "1": "Extensive local validation, matches vendor claims",
        "2": "Local validation shows good performance, minor gaps",
        "3": "Vendor validation only, not yet locally validated",
        "4": "Limited validation, significant uncertainty about local performance",
        "5": "No validation, unproven clinical effectiveness"
      }
    },
    "cybersecurity": {
      "name": "Cybersecurity",
      "weight": 0.15,
      "key_questions": [
        "What attack surfaces does this system introduce?",
        "Is the system protected against adversarial inputs?",
        "Are model extraction attacks mitigated?",
        "Does the system meet NIST 800-53 control requirements?"
      ],
      "assessment_methods": ["Threat modeling", "Penetration testing", "NIST 800-53 control assessment"],
      "scoring_criteria": {
        "1": "Minimal attack surface, strong security controls, FedRAMP authorized",
        "2": "Limited attack surface, standard security controls in place",
        "3": "Moderate attack surface, baseline security controls",
        "4": "Broad attack surface, gaps in security controls identified",
        "5": "Extensive attack surface, significant security vulnerabilities"
      }
    },
    "regulatory": {
      "name": "Regulatory Compliance",
      "weight": 0.10,
      "key_questions": [
        "What regulations apply and are we compliant?",
        "Is FDA clearance required and obtained?",
        "Are ONC HTI-1 transparency requirements met?",
        "Are state-specific AI regulations applicable?"
      ],
      "assessment_methods": ["Regulatory mapping", "Gap analysis", "Compliance documentation review"],
      "scoring_criteria": {
        "1": "Full compliance with all applicable frameworks",
        "2": "Substantially compliant, minor documentation gaps",
        "3": "Partially compliant, remediation plan in place",
        "4": "Significant compliance gaps, regulatory exposure identified",
        "5": "Non-compliant, immediate regulatory risk"
      }
    }
  },
  "overall_risk_calculation": {
    "method": "weighted_average",
    "thresholds": {
      "critical": "weighted_score >= 4.0 OR patient_safety_score == 5",
      "high": "weighted_score >= 3.0",
      "moderate": "weighted_score >= 2.0",
      "low": "weighted_score < 2.0"
    }
  },
  "governance_requirements_by_tier": {
    "critical": {
      "assessment_frequency": "Quarterly",
      "approval_authority": "AI Governance Committee",
      "monitoring": "Continuous real-time",
      "incident_response": "Immediate auto-suspension capability",
      "explainability": "Full model documentation and clinician training"
    },
    "high": {
      "assessment_frequency": "Semi-annually",
      "approval_authority": "AI Review Board",
      "monitoring": "Weekly automated reports",
      "incident_response": "24-hour investigation SLA",
      "explainability": "Structured documentation and clinician briefing"
    },
    "moderate": {
      "assessment_frequency": "Annually",
      "approval_authority": "Governance Lead",
      "monitoring": "Monthly automated reports",
      "incident_response": "Standard incident management",
      "explainability": "Standard documentation"
    },
    "low": {
      "assessment_frequency": "Annually",
      "approval_authority": "System Owner",
      "monitoring": "Quarterly review",
      "incident_response": "Standard incident management",
      "explainability": "Basic documentation"
    }
  }
}
